Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that a block listing application has been made to the London Stock Exchange for 350,000 ordinary shares of one pence each (“Ordinary Shares”) to be admitted to trading on AIM (the “Admission”). The Ordinary Shares that are being reserved under this block listing application will be issued by the Company, as required, in order to satisfy the exercise of share options and vested awards pursuant to the terms of the following share plans:
|Share plan||Number of Ordinary Shares|
|The Craneware plc Schedule 4 Company Share Option Plan (2016)||50,000|
|The Craneware plc Unapproved Company Share Option Plan (2016)||200,000|
|The Craneware plc Long Term Incentive Plan (2016)||100,000|
It is expected that Admission of these Ordinary Shares will become effective on 23 March 2020. When issued, the Ordinary Shares will be credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares.
For further information, please contact:
Keith Neilson, CEO / Craig Preston, CFO
|+44 (0)131 550 3100|
|Peel Hunt (NOMAD and Joint Broker)|
Dan Webster / George Sellar / Andrew Clark
|+44 (0)20 7418 8900|
|Investec Bank (Joint Broker)|
Patrick Robb / Sebastian Lawrence / Henry Reast
|+44 (0)20 7597 5970|
|Alma (Financial PR)|
Caroline Forde / Hilary Buchanan / Helena Bogle
|+44 (0)203 405 0205|
Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware’s value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions.
To learn more, visit craneware.com.